Paul F. Harron, Jr. Lung Center

Thoracic Oncology Research Program

Thoracic Oncology

Faculty members in Penn Medicine's Pulmonary Division, led by Steven Albelda, MD, interact closely with faculty from thoracic surgery, oncology and pathology to conduct cutting-edge diagnostic and therapeutic investigations related to lung cancer and malignant mesothelioma.

Members of the group include:

Pulmonary

Thoracic Surgery

Oncology

Research from this group is supported by an NCI-funded program project, and a grant from the Pennsylvania Department of Health and Foundation.

Specific faculty interests include:

Dr. Abelda

  • Preclinical studies of immunogene therapy for lung cancer and mesothelioma
  • Immune analysis of clinical trials using gene therapy or immunotherapy
  • Mesothelioma and cancer genomics
  • Personalized medicine

Drs. Sterman and Haas

  • Clinical trials using gene therapy or immunotherapy to treat malignant mesothelioma and lung cancer
  • Interventional bronchoscopy treatment of COPD

Dr. Vachani

  • Determination of markers to predict survival after lung cancer surgery
  • Discovery of biomarkers for early detection of lung cancer
  • Gene environment interactions in lung cancer

Dr. Singhal

  • Combining surgery with immunotherapy

Melpo Christofidou-Solomidou, PhD

  • Chemoprevention of lung carcinogenesis and evaluation of anti-carcinogenic effects of common botanicals